CAS 108061-03-6

Ketorolac Ethyl Ester (Ethyl 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate)

CAS: 108061-03-6

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Fórmula: C₁₇H₁₇NO₃

Forma y color: Off-White Solid

Peso molecular: 283.12084

Ref: 45-1A14050

Ketorolac EP Impurity J

CAS: 108061-03-6

Fórmula: C₁₇H₁₇NO₃

Forma y color: Off-White Solid

Peso molecular: 283.33

Ref: 4Z-K-0312

Ethyl (1RS)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (Ketorolac Ethyl Ester)

Producto controlado

CAS: 108061-03-6

Fórmula: C₁₇H₁₇NO₃

Forma y color: Neat

Peso molecular: 283.32

Ref: 86-MM0851.11

Ketorolac Ethyl Ester (Racemic)

Producto controlado

CAS: 108061-03-6

Applications Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic (cas# 108061-03-6) is a useful research chemical.

Fórmula: C₁₇H₁₇NO₃

Forma y color: Neat

Peso molecular: 283.32

Ref: TR-E937730

Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic

CAS: 108061-03-6

Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) is a molecule that can be used in the treatment of cardiac diseases. It is a cardiotonic agent that has been shown to shorten the duration of ventricular fibrillation and restore contractility. This drug also decreases the frequency and severity of angina pectoris and enhances coronary artery blood flow. The most effective dose for this drug is 1.5 mg per kg body weight. It is administered orally or intravenously and should not be used with fatty esters because it may cause hypotension. Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) has been shown to have an effect on metal coordination profiles as well as an activated form of the molecule.

Fórmula: C₁₇H₁₇O₃N

Pureza: Min. 98 Area-%

Forma y color: Off-White Powder

Peso molecular: 283.32 g/mol

Ref: 3D-IE58060

Ketorolac EP Impurity J

CAS: 108061-03-6

Fórmula: C₁₇H₁₇NO₃

Peso molecular: 283.33

Ref: ST-EA-CP-K4010